John J Kim, MD in Darby, PA - Otolaryngology

John J Kim, MD is a Otolaryngology physician based in Darby, Pennsylvania. John J Kim is licensed to practice in Pennsylvania (license number MD035999Y) and his current practice location is 1501 Lansdowne Ave, #209, Darby, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (610) 534-6370.

NPI number for John J Kim is 1235158387 and his current mailing address is 1501 Lansdowne Ave, #209, Darby, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1235158387.

Contact Information

	John J Kim, MD
	1501 Lansdowne Ave, #209, Darby, PA 19023-1333
	(610) 534-6370
	(610) 534-6374

Physician's Profile

Full Name	John J Kim
Gender	Male
Speciality	Otolaryngology
Location	1501 Lansdowne Ave, Darby, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1235158387
Provider Enumeration Date: 07/19/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John J Kim such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235158387	NPI	-	NPPES
6138	Other		AETNA
0053346000	Other		KEYSTONE HEALTH PLAN EAST
0006886200002	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MD035999Y (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John J Kim is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John J Kim, MD 1501 Lansdowne Ave, #209, Darby, PA 19023-1333 Ph: (610) 534-6370	John J Kim, MD 1501 Lansdowne Ave, #209, Darby, PA 19023-1333 Ph: (610) 534-6370

News Archive

New study reveals potential role of TGF-β1 in kidney disease

Fibrosis in the kidney is one of the key causes of progressive renal failure. High levels of the inflammatory molecule TGF-β1 in the kidney tubules due to tissue damage can cause fibrosis as well as nephron degeneration, resulting in loss of kidney function. To clarify the mechanisms regulating TGF-β1-mediated renal fibrosis, Koesters et al expressed high levels of TGF-β1 in renal tubules of mice. Nephron degeneration in this system was mediated by decomposition of the tubular cells. These data suggest that TGF-β1 may play a novel role in cell death of renal cells, thus contributing to renal fibrosis.

UZH leads Europe's largest research on aging

What began in 2012 is now entering its final stages: Europe's largest study on aging. The international research network behind the DO-HEALTH study is led by Heike Bischoff-Ferrari, Professor of Geriatric Medicine and Aging Research at the University of Zurich, and Head of the Department of Geriatrics at the UniversityHospital Zurich and the Waid City Hospital in Zurich, Switzerland.

First Edition: September 20, 2013

Today's headlines include the latest on the Capitol Hill hijinx surrounding efforts to defund the health law and avert a government shutdown.

AtheroNova starts AHRO-001 Phase 1 clinical trial for treatment of atherosclerosis

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers.

ASS234 molecule inhibits aggregation of the Alzheimer's protein

Researchers at Universitat Aut-noma de Barcelona (UAB), the Spanish National Research Council (CSIC) and the University of Barcelona (UB) have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the -amyloid protein, involved in Alzheimer's disease.

Otolaryngology Doctors in Darby, PA

Mahmoud Ghaderi, DO Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1501 Lansdowne Ave Ste 209, Darby, PA 19023 Phone: 484-494-5595
Arash Bahrami, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1501 Lansdowne Ave Ste 209, Darby, PA 19023 Phone: 610-237-3590

John J Kim, MD - Otolaryngology in Darby, PA